NasdaqCM - Nasdaq Real Time Price USD
Jasper Therapeutics, Inc. (JSPR)
4.7450
+0.1850
+(4.06%)
As of 1:28:27 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-62,602
-62,602
-52,067
-45,858
-33,678
Investing Cash Flow
-532
-532
-267
-576
-2,428
Financing Cash Flow
47,884
47,884
100,971
55
100,969
End Cash Position
72,054
72,054
87,304
38,667
85,046
Capital Expenditure
-552
-552
-267
-576
-2,428
Issuance of Capital Stock
47,195
47,195
101,479
--
10,750
Free Cash Flow
-63,154
-63,154
-52,334
-46,434
-36,106
12/31/2021 - 1/10/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TIL Instil Bio, Inc.
19.32
-5.85%
ADIL Adial Pharmaceuticals, Inc.
0.7010
-3.84%
LCTX Lineage Cell Therapeutics, Inc.
0.4743
+0.49%
BCYC Bicycle Therapeutics plc
8.29
-4.44%
PTGX Protagonist Therapeutics, Inc.
45.02
-2.47%
ACRV Acrivon Therapeutics, Inc.
1.9050
-4.75%
RLMD Relmada Therapeutics, Inc.
0.7208
+4.46%
NMRA Neumora Therapeutics, Inc.
0.7579
+6.61%
TARA Protara Therapeutics, Inc.
4.2200
+0.48%
PYXS Pyxis Oncology, Inc.
1.0750
-0.46%